TY  - JOUR 
AU  - Ortiz-Fernández, L.
AU  - Carmona, E.G.
AU  - Kerick, M.
AU  - Lyons, P.
AU  - Carmona, F.D.
AU  - Mejías, R.L.
AU  - Khor, C.C.
AU  - Grayson, P.C.
AU  - Tombetti, E.
AU  - Jiang, L.
AU  - Direskeneli, H.
AU  - Saruhan-Direskeneli, G.
AU  - Callejas-Rubio, J.-L.
AU  - Vaglio, A.
AU  - Salvarani, C.
AU  - Hernández-Rodríguez, J.
AU  - Cid, M.C.
AU  - Morgan, A.W.
AU  - Merkel, P.A.
AU  - Burgner, D.
AU  - Smith, K.G.C.
AU  - González-Gay Mantecón, Miguel Ángel
AU  - Sawalha, A.H.
AU  - Martin, J.
AU  - Marquez, A.
PY  - 2023
SN  - 1468-2060
UR  - http://hdl.handle.net/20.500.11940/21587
AB  - Objectives The number of susceptibility loci currently associated with vasculitis is lower than in other immune-mediated diseases due in part to small cohort sizes, a consequence of the low prevalence of vasculitides. This study aimed to identify new...
LA  - eng
KW  - Humans
KW  - CTLA-4 Antigen
KW  - Drug Repositioning
KW  - Genetic Predisposition to Disease
KW  - Systemic Vasculitis
KW  - Vasculitis
KW  - Apoptosis Regulatory Proteins
TI  - Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing
DO  - 10.1136/ard-2022-223697
T2  - Annals of the Rheumatic Diseases
M2  - 837
KW  - AS Santiago
KW  - CHUS
VL  - 82
ER  -